TBIO: Koefisien rega marang pendapatan Codex DNA
Telesis Bio, Inc. (TBIO) generates revenue through the sale of automated gene synthesizers and related materials. The median P/S from GURU.Markets is used to analyze the trend, where the metric value is 0.30. While the environmental efficiency of the systems reduces the carbon footprint of laboratories, operating losses and slow technology adoption create significant risks for the company's capitalization within the synthetic biology sector.
Rincian metrik lan analitis perusahaan Codex DNA (TBIO)
- rega saiki lan proyeksi nilai saham:
- informasi kapitalisasi pasar:
- rincian nilai buku perusahaan:
- indikator beban kredit lan likuiditas emiten:
Koefisien Total Utang marang Modal Telesis Bio, Inc.|TBIO - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang modal Telesis Bio, Inc|TBIO - Gunggung utang perusahaan|Utang marang nilai buku Codex DNA|TBIO - Kewajiban jangka dawa perusahaan|Gunggunge utang jangka cendhak Telesis Bio|Rasio likuiditas perantara telesisbio.com
- data bathi lan kelipatan valuasi:
TBIO - Bathi resik|Bathi sing dikarepake Telesis Bio, Inc.|TBIO - Pangali P/E|Kapitalisasi marang proyeksi bathi Telesis Bio Inc.|TBIO - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Codex DNA|TBIO - Bathi operasional EBITDA|Bathi saben saham sajrone 12 wulan pungkasan Telesis Bio|TBIO - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan telesisbio.com|TBIO - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Telesis Bio, Inc.
- indikator pendapatan dodolan lan penghasilan bisnis:
Analisis umum perusahaan:TBIO (telesisbio.com)
The efficiency of DNA synthesis system logistics and reagent supplies directly impacts the price-to-sales valuation of Telesis Bio, Inc. (TBIO). This multiple compares the company's total market capitalization to its annual revenue, allowing investors to identify asset overheating when quotes deviate from historical norms and determine the equilibrium point to assess the stability of invested capital.
Karo sapa Telesis Bio, Inc. saingan
Rasio rega marang pendapatan TEM (Tempus AI)|Multiplikator P/S QGEN (Qiagen)|Koefisien rega marang pendapatan Ionis Pharmaceuticals, Inc. (IONS)|RGEN - Rasio rega marang pendapatan|Rega marang dodolan Avidity Corp|CRSP (CRISPR Therapeutics AG) - Kapitalisasi marang pendapatan|genedx.com - Rasio kapitalisasi pasar marang pendapatan|RARE (Ultragenyx) - Multiplikator P/S|Beam Therapeutics Inc (BEAM) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Sarepta Therapeutics Inc (SRPT)|Twist Bioscience Corp - Rasio kapitalisasi marang pendapatan|Multiplikator P/S TXG (10x Genomics, Inc.)|NTLA - Kapitalisasi marang pendapatan|STOK: Kapitalisasi marang pendapatan|Koefisien rega marang pendapatan BioLife Solutions Inc BLFS|WVE (Wave Life Sciences Corp) - Kapitalisasi marang pendapatan|MAZE: Kapitalisasi marang volume dodolan|SION (Sionna Therapeutics Inc) - Multiplikator P/S|Rasio rega marang pendapatan PRME|Multiplikator P/S TSHA|Koefisien rega marang pendapatan uniQure NV|Rasio rega marang pendapatan MeiraGTx PLC MGTX|REGENXBIO Corp (RGNX) - Rega marang dodolan|Solid Biosciences Inc. - Multiplikator P/S|OCGN (ocugen.com) - Rasio kapitalisasi marang pendapatan|PacBio (PACB) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan BNTC|DSGN (Design Pharma) - Multiplikator P/S|Multiplikator P/S Rocket Corp|Kapitalisasi marang pendapatan FDMT (4D Molecular Therapeutics)|Kapitalisasi marang volume dodolan LXEO|Multiplikator P/S KRRO (Korro Bio)|Editas Medicine Inc (EDIT) - Rega marang dodolan|SLN - Rasio rega marang pendapatan|PRQR: Rasio rega marang pendapatan|CDXS: Multiplikator P/S|Rega marang dodolan sangamo.com (SGMO)|Rasio rega marang pendapatan Nautilus Biotechnology, Inc.|Metagenomi Inc. (MGX) - Koefisien rega marang pendapatan|Multiplikator P/S DTIL|Koefisien rega marang pendapatan generationbio.com|Rasio rega marang pendapatan Boundless Bio, Inc. BOLD|Koefisien rega marang pendapatan Exicure Inc. (XCUR)|IMNN: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan PHIO (Phio Pharmaceuticals)|MBIO: Multiplikator P/S|RNAZ (TransCode Therapeutics, Inc.) - Rasio rega marang pendapatan|BNGO (Bionano Genomics Inc.) - Multiplikator P/S|adnas.com (APDN) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan bluebird bio (BLUE)|IPA - Rega marang dodolan|Omega - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan OMIC|Regulus Therapeutics - Multiplikator P/S|Koefisien rega marang pendapatan syros.com SYRS|TRACON Pharmaceuticals, Inc. (TCON) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan UBX
